In Slugterra: Slug It Out 2 we'll once again take on the role of Eli Shane that, together with his friends Pronto, Trixie, and Kord, and your invaluable help, will become an expert slug thrower in ...

With more than 50 years’ experience in diversified international business, Eli is a well-established and prolific journalist, having authored nearly 2,000 articles on job market, workplace ...

One of Eli Lilly's potential competitors in the weight loss market just reported unimpressive trial results. The company could benefit from the government coverage of its weight loss medicines.

Telehealth firm Ro has partnered with Eli Lilly And Co (NYSE:LLY) to enhance patient access to Zepbound (tirzepatide) single-dose vials for obesity treatment. Through LillyDirect, Ro will provide ...

On this episode of Fortune’s Leadership Next podcast, host Diane Brady talks to Eli Lilly chair and CEO Dave Ricks. They discuss the challenges of developing products that counter diseases and ...

Slugs are the bane of many gardeners' lives as these slimy invaders can quickly reduce your hard work to a few sad, nibbled leaves. Snails are most active in the cooler, damp evenings and early ...

Eli Lilly has performed quite well over the past 40 years. The company was the first to mass-produce insulin. The stock trades at a high valuation. Given that Eli Lilly has been public for roughly ...

Adults taking Zepbound lost 47% more weight on average than those taking Wegovy, according to clinical trial data from drugmaker Eli Lilly. In a head-to-head comparison of the two GLP-1 drugs ...